Molecular dynamics analysis of the wild type and dF508 mutant structures of the human CFTR-nucleotide binding domain 1

被引:17
作者
Bisignano, Paola [1 ]
Moran, Oscar [1 ]
机构
[1] CNR, Ist Biofis, I-16149 Genoa, Italy
关键词
Cystic fibrosis; Nuclear binding domain; dF508; CFTR; TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS MUTATION; DELTA-F508; MUTATION; CHLORIDE-CHANNEL; FORCE-FIELD; SIMULATIONS; ACTIVATORS; DEFECTS; PROTEIN; MODEL;
D O I
10.1016/j.biochi.2009.09.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations of CFTR (Cystic Fibrosis transmembrane Conductance Regulator), a membrane protein expressed in the epithelium that forms a chloride channel, cause a chronic, developmental and hereditary disease, known as Cystic Fibrosis. The most common mutation is the deletion of F508, a residue present in the first nucleotide binding domain (NBD1). We studied the thermodynamic properties of NBD1 wild type (WT) and mutant (dF508), starting from the crystallographic structures in the Protein Data Bank using the techniques of Molecular Dynamics. The two structures were similarly stable at room temperature, showed no change enthalpy or entropy, maintaining the same dimensions and the same order of magnitude of atomic fluctuations; the only difference was the energy of interaction with the solvent, in which the mutant appears slightly disadvantaged; these differences between the two models are at microscopic level and relate to local variations (in residues at 8 angstrom from F508) of the surface exposed to the solvent. We also found a decrease in the mutant of about 30 times of affinity for ATP compared to WT. (C) 2009 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:51 / 57
页数:7
相关论文
共 28 条
[1]   Ligand binding affinities from MD simulations [J].
Åqvist, J ;
Luzhkov, VB ;
Brandsdal, BO .
ACCOUNTS OF CHEMICAL RESEARCH, 2002, 35 (06) :358-365
[2]   DEFECTIVE INTRACELLULAR-TRANSPORT AND PROCESSING OF CFTR IS THE MOLECULAR-BASIS OF MOST CYSTIC-FIBROSIS [J].
CHENG, SH ;
GREGORY, RJ ;
MARSHALL, J ;
PAUL, S ;
SOUZA, DW ;
WHITE, GA ;
ORIORDAN, CR ;
SMITH, AE .
CELL, 1990, 63 (04) :827-834
[3]   Misfolding of the cystic fibrosis transmembrane conductance regulator and disease [J].
Cheung, Joanne C. ;
Deber, Charles M. .
BIOCHEMISTRY, 2008, 47 (06) :1465-1473
[4]   Mutations in the nucleotide binding domain 1 signature motif region rescue processing and functional defects of cystic fibrosis transmembrane conductance regulator ΔF508 [J].
deCarvalho, ACV ;
Gansheroff, LJ ;
Teem, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (39) :35896-35905
[5]   The F508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR [J].
Du, K ;
Sharma, M ;
Lukacs, GL .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2005, 12 (01) :17-25
[6]   Identification of CFTR activators and inhibitors: chance or design? [J].
Galietta, LJV ;
Moran, O .
CURRENT OPINION IN PHARMACOLOGY, 2004, 4 (05) :497-503
[7]   Ligand binding affinity prediction by linear interaction energy methods [J].
Hansson, T ;
Marelius, J ;
Aqvist, J .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1998, 12 (01) :27-35
[8]   Delta F508-CFTR channels: Kinetics, activation by forskolin, and potentiation by xanthines [J].
Haws, CM ;
Nepomuceno, IB ;
Krouse, ME ;
Wakelee, H ;
Law, T ;
Xia, Y ;
Nguyen, H ;
Wine, JJ .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1996, 270 (05) :C1544-C1555
[9]   Model@Home: distributed computing in bioinformatics using a screensaver based approach [J].
Krieger, E ;
Vriend, G .
BIOINFORMATICS, 2002, 18 (02) :315-318
[10]   Increasing the precision of comparative models with YASARA NOVA - a self-parameterizing force field [J].
Krieger, E ;
Koraimann, G ;
Vriend, G .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2002, 47 (03) :393-402